CJC-1295-related peptides are studied in growth-hormone-releasing hormone receptor assays, while ipamorelin is studied in ghrelin-receptor signaling systems. A blend permits comparative or combined assay work but makes component-specific attribution more difficult.
Batch tested
Representative product imagery. Verify the physical label and lot documentation on receipt.
Growth Signaling
CJC-1295 + Ipamorelin
In stock·Ships in 1–2 business days
CJC-1295 and Ipamorelin combined in a balanced 5 mg + 5 mg blend. Each unit is labeled with a traceable lot code and links to its corresponding analytical report.
Select size1 option
Select pack sizeSave 18% on kits
Peptide$69.99
48 ready to shipTransparent volume pricing10-vial peptide kits save 18%.
Batch tested COA available Secure checkout US & EU dispatch
Compound context
What researchers study
This dual-compound reference blend is supplied for comparative analytical and receptor-signaling research.
Growth-signaling research studies receptor activation, intracellular signaling cascades, and measurable changes in controlled cell-based or biochemical systems. Synthetic reference materials help laboratories compare method performance and pathway responses.
A receptor or signaling observation describes the specific experimental system only. Analytical identity and purity do not establish biological effectiveness, safety, sterility, or suitability for administration.
Scope limitA blend report must be matched to the exact lot and composition.
Serenity Compounds is not a compounding pharmacy or chemical compounding facility as defined under Section 503A of the Federal Food, Drug, and Cosmetic Act.
Common laboratory focus
Blend analysis must identify and quantify each peptide independently, account for overlapping peaks or fragments, and verify the stated ratio. A total purity value alone cannot establish the amount or integrity of each component.
Compatibility studies monitor whether either component changes the other's recovery, adsorption, aggregation, or degradation profile. Signaling observations are limited to controlled receptor models and do not establish endocrine, muscle, recovery, or clinical effects.
Quality documentation
Know what your laboratory receives.
Batch records are published for transparency and should be independently reviewed by qualified research personnel.
Current certificateCJC-1295 + Ipamorelin · Lot SC-2607Identity confirmed · Purity report availableView report
- Tamper-evident packaging
- Lot and SKU traceability
- Independent analytical review
Continue exploring
